A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms
IITG-PPT
1 other identifier
interventional
100
1 country
1
Brief Summary
Existing data suggest that both trauma and Post-Traumatic Stress Disorder (PTSD) are very common among individuals with psychosis. The presence of PTSD symptoms in psychosis is associated with worse clinical outcomes and poorer social functioning. However, PTSD is a poorly attended and poorly studied condition among this population. Research to date indicates that trauma-focused treatments are safe and effective for PTSD, even when psychotic comorbidity is present. Recent systematic reviews of psychological interventions for trauma in psychosis found that are effective in reducing trauma symptoms, suggesting that they should be implemented in front-line services. Nonetheless, larger confirmative trials are required to form robust conclusions.The aim of this project is to examine the efficacy of comprehensive third-generation protocol for people with comorbid trauma and psychosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2022
CompletedFirst Submitted
Initial submission to the registry
October 26, 2022
CompletedFirst Posted
Study publicly available on registry
November 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
ExpectedApril 25, 2025
April 1, 2025
3.9 years
October 26, 2022
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from posttraumatic symptoms at 12 weeks and 6 months
International Trauma Questionnaire (ITQ; Cloitre, et al., 2018).Higher scores mean a worse outcome.
Change baseline, 12 weeks, and 6 months
Change from psychotic symptoms at 12 weeks and 6 months
Psychotic Symtoms Rating Scale (Haddock et al., 1999).Higher scores mean a worse outcome.
Change baseline, 12 weeks, and 6 months
Change from psychopathological symptoms at 12 weeks and 6 months
Symptom Checklist 45-SCL-90\_r brief (Davison et al., 1997). Higher scores mean a worse outcome.
Change baseline, 12 weeks, and 6 months
Change from dissociative symptoms at 12 weeks and 6 months
The Dissociative Experience Scale Taxon (DES-T; Waller \& Ross, 1997). Higher scores mean a worse outcome.
Change baseline, 12 weeks, and 6 months
Secondary Outcomes (5)
Change from Personal and Social functioning at 12 weeks and 6 months
Change baseline, 12 weeks, and 6 months
Change from Wellbeing at 12 weeks and 6 months
Change baseline, 12 weeks, and 6 months
Change from satisfaction with life at 12 weeks and 6 months
Change baseline, 12 weeks, and 6 months
Change from Attachment at 12 weeks and 6 months
Change baseline, 12 weeks, and 6 months
Change from Emotion Regulation at 12 weeks and 6 months
Change baseline, 12 weeks, and 6 months
Study Arms (2)
TAU + waiting list
OTHERTreatment as usual
TAU + A comprehensive third-generation intervention
EXPERIMENTALhe protocol will bedeveloped following the three stages of recovery from trauma (Herman, 2015): first, focusing on establishing the therapeutic alliance and safety; second, focusing on recounting and re-processing the traumatic event; and third, focusing on reconnecting with others and with life despite the trauma experienced. The therapy will be administered in 11 90-minute individual sessions per week, combining strategically ACT, Mindfulness, EMDR as well as Positive Psychology interventions.
Interventions
This is a individual intervention with with a total of 12 sessions: Session 1. Constructing the Therapy Experience. Session 2. Life history and immediate reactions to trauma. Session 3. Preparing to deal with trauma. Session 4. Regulating emotions. Session 5-9. Focusing on retelling and processing the traumatic event (EMDR PHASES\_PHASE 3: Evaluation of the traumatic memory. EMDR PHASE 4: Desensitization. EMDR PHASE 5: Positive Belief Installation. PHASE 6: Body Scan). Session 9. Re-evaluating traumatic memory and self-care through positive emotions. Session 10. Cultivating self-kindness. Session 11. Developing a healthy identity. Session 12. Building a better future
Eligibility Criteria
You may qualify if:
- Be between the ages of 18 and 65 fluent enough in Spanish language;
- Meet the criteria for a diagnosis of a psychotic spectrum disorder or a mood disorder with psychotic symptoms according to MINI (Sheeman et al., 1997);
- Meet PTSD diagnostic criteria according to the Clinician-Administered PTSD Scale (CAPS; Blake et al., 1995)
You may not qualify if:
- Those who have a diagnosis of substance or alcohol abuse or dependence in the 30 days prior to participation in the study
- To have a severe neurocognitive problems or brain damage that interfere with the basic processing of information in psychotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carmen Valiente
Pozuelo de Alarcón, Madrid, 28223, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carmen Valiente, Ph.D.
Universidad Complutense de Madrid
- PRINCIPAL INVESTIGATOR
Regina Espinosa, Ph.D.
Universidad Camilo Jose Cela
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2022
First Posted
November 17, 2022
Study Start
May 27, 2022
Primary Completion
April 30, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code